immuuntherapie, ipilimumab, melanomen, GP-100

MELANOMA - Skin cancer

Information on current developments in both regular and alternative or complementary treatments for melanoma and resources at all stages. A melanoma is a malignant form of subcutaneous skin cancer.

Scroll down left column to articles more or less in alphabetical order are classified.
Among both regular and among complementary also provides much information about recent developments in melanoma. There in alphabetical scrolling list to melanoma.
If you want to support us you can do so through a donation: See registration OPS Cancer News are among such patients experience .

Immunotherapy for melanoma: Ipilimumab, an immune therapy drug shows promising results in longer survival among patients with grade III and IV melanoma who had previously been treated extensively. Known oncologist calls for changes to clinical practice standards Ipilimubab add to treatment of recurrent metastatic melanoma stage III / IV. Ipilimumab FDA approves drug for advanced melanoma as well Article updated March 28, 2011

Ipilimumab, an immune therapy drug shows promising results in longer survival among patients with grade III and IV melanoma who had previously been treated extensively. Ipilimubab FDA official status as a treatment of recurrent metastatic melanoma stage III / IV. Article updated March 28, 2011